Literature DB >> 7395865

Gyrate atrophy of the choroid and retina with hyperornithinemia: biochemical and histologic studies and response to vitamin B6.

N G Kennaway, R G Weleber, N R Buist.   

Abstract

Four patients with hyperomithinemia and gyrate atrophy of the choroid and retina age described. In vivo response to vitamin B6 is documented in three of the four patients by significant reduction of fasting serum ornithine and increase of lysine after oral B6 supplementation. Oral glucose tolerance testing in one patient resulted in marked changes in serum ornithine and lysine concentrations, in addition to mild glucose intolerance. Histochemical staining of punch muscle biopsies showed intracellular inclusions in type 2 muscle fibers. Tubular aggregates, approximately 60 nm in diameter and adjacent to the sarcoplasmic membrane, were seen on electron microscopy. Obligate heterozygotes had a mean serum ornithine slightly higher than normal, but there was considerable overlap with the normal range. Oral ornithine tolerance tests distinguished carriers from controls in only one of five cases. Deficient activity of ornithine ketoacid aminotransferase (OKT) in cultured skin fibroblasts was documented in all four patients. Approximately half-normal levels were found in obligate heterozygotes. In vitro response to B6 was manifest by increased OKT activity at increased concentrations of pyridoxal phosphate in fibroblasts from the patients.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7395865      PMCID: PMC1686127     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  34 in total

1.  Oculocraniosomatic neuromuscular disease with "ragged-red" fibers.

Authors:  W Olson; W K Engel; G O Walsh; R Einaugler
Journal:  Arch Neurol       Date:  1972-03

2.  Raised plasma-ornithine and gyrate atrophy of the choroid and retina.

Authors:  O Simell; K Takki
Journal:  Lancet       Date:  1973-05-12       Impact factor: 79.321

3.  The properties, developmental formation, and estrogen induction of ornithine aminotransferase in rat tissues.

Authors:  A Herzfeld; W E Knox
Journal:  J Biol Chem       Date:  1968-06-25       Impact factor: 5.157

4.  Aggregates of tubules in human cardiac muscle cells.

Authors:  B J Maron; V J Ferrans
Journal:  J Mol Cell Cardiol       Date:  1974-06       Impact factor: 5.000

5.  Tubular aggregates in type II muscle fibers: ultrastructural and histochemical correlation.

Authors:  W K Engel; D W Bishop; G G Cunningham
Journal:  J Ultrastruct Res       Date:  1970-06

6.  Familial pancreatitis.

Authors:  A Logan; C P Schlicke; G B Manning
Journal:  Am J Surg       Date:  1968-01       Impact factor: 2.565

7.  Ornithine-ketoacid transaminase activity in human skin and amniotic fluid cell culture.

Authors:  V E Shih; J D Schulman
Journal:  Clin Chim Acta       Date:  1970-01       Impact factor: 3.786

8.  The successful treatment of homocystinuria with pyridoxine.

Authors:  G W Barber; G L Spaeth
Journal:  J Pediatr       Date:  1969-09       Impact factor: 4.406

9.  Pyridoxine-responsive genetic disease.

Authors:  S H Mudd
Journal:  Fed Proc       Date:  1971 May-Jun

10.  Cystathioninuria: nature of the defect.

Authors:  G W Frimpter
Journal:  Science       Date:  1965-09-03       Impact factor: 47.728

View more
  12 in total

1.  Gyrate atrophy of the choroid and retina: characterization of mutant ornithine aminotransferase and mechanism of response to vitamin B6.

Authors:  N G Kennaway; L Stankova; M K Wirtz; R G Weleber
Journal:  Am J Hum Genet       Date:  1989-03       Impact factor: 11.025

2.  Inheritance of ornithine aminotransferase gene, mRNA, and enzyme defect in a family with gyrate atrophy of the choroid and retina.

Authors:  Y Hotta; N G Kennaway; R G Weleber; G Inana
Journal:  Am J Hum Genet       Date:  1989-03       Impact factor: 11.025

3.  Pyridoxine effects on ornithine ketoacid transaminase activity in fibroblasts from carriers of two forms of gyrate atrophy of the choroid and retina.

Authors:  V E Shih; R Mandell; E L Berson
Journal:  Am J Hum Genet       Date:  1988-12       Impact factor: 11.025

4.  Splicing defect at the ornithine aminotransferase (OAT) locus in gyrate atrophy.

Authors:  A I McClatchey; D L Kaufman; E L Berson; A J Tobin; V E Shih; J F Gusella; V Ramesh
Journal:  Am J Hum Genet       Date:  1990-11       Impact factor: 11.025

Review 5.  B6-responsive disorders: a model of vitamin dependency.

Authors:  Peter T Clayton
Journal:  J Inherit Metab Dis       Date:  2006 Apr-Jun       Impact factor: 4.982

6.  Gyrate atrophy of the choroid and retina with hyperornithinemia: characterization of mutant liver L-ornithine:2-oxoacid aminotransferase kinetics.

Authors:  I Sipilä; O Simell; J J O'Donnell
Journal:  J Clin Invest       Date:  1981-06       Impact factor: 14.808

7.  Molecular basis of ornithine aminotransferase deficiency in B-6-responsive and -nonresponsive forms of gyrate atrophy.

Authors:  V Ramesh; A I McClatchey; N Ramesh; L A Benoit; E L Berson; V E Shih; J F Gusella
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

8.  Biochemical and therapeutical studies in a case of atrophia gyrata.

Authors:  W Behrens-Baumann; U König; K Schröder; I Hansmann; U Langenbeck
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1982       Impact factor: 3.117

Review 9.  Gyrate atrophy of the choroid and retina. Approaches to therapy.

Authors:  R G Weleber; N G Kennaway; N R Buist
Journal:  Int Ophthalmol       Date:  1981-08       Impact factor: 2.031

10.  Pyridoxine-responsive gyrate atrophy of the choroid and retina: clinical and biochemical correlates of the mutation A226V.

Authors:  J Michaud; G N Thompson; L C Brody; G Steel; C Obie; G Fontaine; K Schappert; C G Keith; D Valle; G A Mitchell
Journal:  Am J Hum Genet       Date:  1995-03       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.